Company intelligence / Profile preview

Enox

Ownership: Private
Development stage: Other

Overview

There appear to be two distinct companies using the "ENOX" name. Enox Biopharma Inc. (US-based) develops proprietary technology to embed nitric oxide into polymer-based or silicone-based medical devices aimed at infection prevention and wound healing. No published clinical results found; company is described as emerging with advanced technology. ENOX PHARMA LTD / Enox Pharma (UK/Sweden-based) distributes life science products, focusing on affordable cancer screening diagnostics using AI-enabled solutions. No clinical trial data provided for this entity.

Therapeutic areas: DermatologyOncologyInfectious Diseases
Modalities: DeviceDiagnostic device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Enox.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enox.

Explore the full profile